These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38184515)

  • 1. Long-term results of regenerative treatment of intrabony defects: a cohort study with 5-year follow-up.
    Lee JH; Jeong SN
    BMC Oral Health; 2024 Jan; 24(1):34. PubMed ID: 38184515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term stability of adjunctive use of enamel matrix protein derivative on porcine-derived xenograft for the treatment of one-wall intrabony defects: A 4-year extended follow-up of a randomized controlled trial.
    Lee JH; Jeong SN
    J Periodontol; 2022 Feb; 93(2):229-236. PubMed ID: 34050681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive use of enamel matrix derivatives to porcine-derived xenograft for the treatment of one-wall intrabony defects: Two-year longitudinal results of a randomized controlled clinical trial.
    Lee JH; Kim DH; Jeong SN
    J Periodontol; 2020 Jul; 91(7):880-889. PubMed ID: 31811645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane.
    Iorio-Siciliano V; Andreuccetti G; Blasi A; Matarasso M; Sculean A; Salvi GE
    J Periodontol; 2014 Oct; 85(10):1342-50. PubMed ID: 24835417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate.
    Pietruska M; Pietruski J; Nagy K; Brecx M; Arweiler NB; Sculean A
    Clin Oral Investig; 2012 Aug; 16(4):1191-7. PubMed ID: 21881869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-year results following regenerative periodontal surgery of advanced intrabony defects with enamel matrix derivative alone or combined with a synthetic bone graft.
    Hoffmann T; Al-Machot E; Meyle J; Jervøe-Storm PM; Jepsen S
    Clin Oral Investig; 2016 Mar; 20(2):357-64. PubMed ID: 26174080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review.
    Esposito M; Grusovin MG; Papanikolaou N; Coulthard P; Worthington HV
    Eur J Oral Implantol; 2009; 2(4):247-66. PubMed ID: 20467602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
    J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medium- and long-term clinical benefits of periodontal regenerative/reconstructive procedures in intrabony defects: Systematic review and network meta-analysis of randomized controlled clinical studies.
    Stavropoulos A; Bertl K; Spineli LM; Sculean A; Cortellini P; Tonetti M
    J Clin Periodontol; 2021 Mar; 48(3):410-430. PubMed ID: 33289191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified minimally invasive surgical technique in human intrabony defects with or without regenerative materials-10-year follow-up of a randomized clinical trial: Tooth retention, periodontitis recurrence, and costs.
    Cortellini P; Cortellini S; Bonaccini D; Tonetti MS
    J Clin Periodontol; 2022 Jun; 49(6):528-536. PubMed ID: 35415940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects.
    Sculean A; Windisch P; Szendröi-Kiss D; Horváth A; Rosta P; Becker J; Gera I; Schwarz F
    J Periodontol; 2008 Oct; 79(10):1991-9. PubMed ID: 18834256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcomes of periodontal regeneration with enamel matrix derivative: A retrospective cohort study with a mean follow-up of 10 years.
    De Ry SP; Roccuzzo A; Lang NP; Sculean A; Salvi GE
    J Periodontol; 2022 Apr; 93(4):548-559. PubMed ID: 34258767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
    Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
    J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EDTA gel root conditioning: lack of effect on clinical and radiographic outcomes of intrabony defect treatment with enamel matrix derivative.
    Parashis AO; Tsiklakis K; Tatakis DN
    J Periodontol; 2006 Jan; 77(1):103-10. PubMed ID: 16579710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiographic angle width as predictor of clinical outcomes following regenerative periodontal therapy with enamel matrix derivative: a retrospective cohort study with a mean follow-up of at least 10 years.
    Roccuzzo A; Ettmayer J; De Ry SP; Imber JC; Sculean A; Salvi GE
    Quintessence Int; 2023 May; 54(5):384-392. PubMed ID: 36661359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
    Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
    J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.
    Yilmaz S; Cakar G; Yildirim B; Sculean A
    J Clin Periodontol; 2010 Jun; 37(6):544-50. PubMed ID: 20507378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
    Velasquez-Plata D; Scheyer ET; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):433-40. PubMed ID: 11990445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enamel matrix derivative in the treatment of human intrabony osseous defects.
    Okuda K; Momose M; Miyazaki A; Murata M; Yokoyama S; Yonezawa Y; Wolff LF; Yoshie H
    J Periodontol; 2000 Dec; 71(12):1821-8. PubMed ID: 11156038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects.
    Esposito M; Grusovin MG; Coulthard P; Worthington HV
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003875. PubMed ID: 16235343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.